Friday - November 1, 2024
Ropes & Gray: Takeda Pharmaceuticals Announces Multi-Target Collaboration Up to $1.2B With Degron Therapeutics
May 25, 2024
BOSTON, Massachusetts, May 25 -- Ropes and Gray, a law firm, issued the following news:

Ropes & Gray advised Takeda Pharmaceuticals in a collaboration and exclusive license agreement with Degron Therapeutics to discover and develop novel molecular glue degraders for multiple targets in oncology, neuroscience and inflammation. The transaction was announced on May 23.

Takeda and Degron will collaborate to use Degron's GlueXplorer platform to identify, validate and opt . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products